Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

HIV-associated neurocognitive disorders: perspective on management strategies.

Nabha L, Duong L, Timpone J.

Drugs. 2013 Jun;73(9):893-905. doi: 10.1007/s40265-013-0059-6. Review.

2.

HIV-associated neurological disorders: a guide to pharmacotherapy.

Tan IL, McArthur JC.

CNS Drugs. 2012 Feb 1;26(2):123-34. doi: 10.2165/11597770-000000000-00000. Review.

PMID:
22201342
3.

HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.

Chan P, Brew BJ.

Curr HIV/AIDS Rep. 2014 Sep;11(3):317-24. doi: 10.1007/s11904-014-0221-0. Review.

PMID:
24966139
4.

CSF penetration by antiretroviral drugs.

Eisfeld C, Reichelt D, Evers S, Husstedt I.

CNS Drugs. 2013 Jan;27(1):31-55. doi: 10.1007/s40263-012-0018-x. Review.

PMID:
23160938
5.

Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus.

Bogoch II, Davis BT, Venna N.

J Infect. 2011 Sep;63(3):236-9. doi: 10.1016/j.jinf.2011.05.011.

PMID:
21658774
6.

Current understanding of HIV-associated neurocognitive disorders pathogenesis.

Gannon P, Khan MZ, Kolson DL.

Curr Opin Neurol. 2011 Jun;24(3):275-83. doi: 10.1097/WCO.0b013e32834695fb. Review.

7.

HIV-associated neurocognitive disorders (HAND).

Elbirt D, Mahlab-Guri K, Bezalel-Rosenberg S, Gill H, Attali M, Asher I.

Isr Med Assoc J. 2015 Jan;17(1):54-9. Review.

8.

Treatment of HIV in the CNS: effects of antiretroviral therapy and the promise of non-antiretroviral therapeutics.

Peluso MJ, Spudich S.

Curr HIV/AIDS Rep. 2014 Sep;11(3):353-62. doi: 10.1007/s11904-014-0223-y.

PMID:
25063356
9.

Role of the macrophage in HIV-associated neurocognitive disorders and other comorbidities in patients on effective antiretroviral treatment.

Rappaport J, Volsky DJ.

J Neurovirol. 2015 Jun;21(3):235-41. doi: 10.1007/s13365-015-0346-y. Review.

10.

Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistence.

Gill AJ, Kolson DL.

Curr HIV/AIDS Rep. 2014 Sep;11(3):325-35. doi: 10.1007/s11904-014-0210-3. Review.

11.

Neurocognitive impairment and neuroCART.

Wright E.

Curr Opin HIV AIDS. 2011 Jul;6(4):303-8. doi: 10.1097/COH.0b013e3283477c46. Review.

PMID:
21546833
12.

Pathogenesis of HIV in the central nervous system.

Valcour V, Sithinamsuwan P, Letendre S, Ances B.

Curr HIV/AIDS Rep. 2011 Mar;8(1):54-61. doi: 10.1007/s11904-010-0070-4. Review.

13.

Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND).

Ndhlovu LC, Umaki T, Chew GM, Chow DC, Agsalda M, Kallianpur KJ, Paul R, Zhang G, Ho E, Hanks N, Nakamoto B, Shiramizu BT, Shikuma CM.

J Neurovirol. 2014 Dec;20(6):571-82. doi: 10.1007/s13365-014-0279-x.

14.

Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review.

Cysique LA, Brew BJ.

Neuropsychol Rev. 2009 Jun;19(2):169-85. doi: 10.1007/s11065-009-9092-3. Review.

PMID:
19424802
15.

Therapy recommendations for HIV-associated neurocognitive disorders.

Zirulnik JL.

JAMA. 2008 Dec 3;300(21):2482; author reply 2482-3. doi: 10.1001/jama.2008.733. No abstract available.

PMID:
19050186
16.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
17.

HIV, antiretroviral therapies, and the brain.

Liner KJ 2nd, Ro MJ, Robertson KR.

Curr HIV/AIDS Rep. 2010 May;7(2):85-91. doi: 10.1007/s11904-010-0042-8. Review.

PMID:
20425562
18.

HIV pharmacology: barriers to the eradication of HIV from the CNS.

McGee B, Smith N, Aweeka F.

HIV Clin Trials. 2006 May-Jun;7(3):142-53. Review.

PMID:
16880170
19.

Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1.

Taiwo B, Hicks C, Eron J.

J Antimicrob Chemother. 2010 Jun;65(6):1100-7. doi: 10.1093/jac/dkq096. Review.

Items per page

Supplemental Content

Support Center